Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Infect Immun
2005 Jun 01;736:3307-12. doi: 10.1128/IAI.73.6.3307-3312.2005.
Show Gene links
Show Anatomy links
A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin.
Mve-Obiang A, Lee RE, Umstot ES, Trott KA, Grammer TC, Parker JM, Ranger BS, Grainger R, Mahrous EA, Small PL.
???displayArticle.abstract???
Mycobacterium ulcerans, the causative agent of Buruli ulcer, produces a macrolide toxin, mycolactone A/B, which is thought to play a major role in virulence. A disease similar to Buruli ulcer recently appeared in United States frog colonies following importation of the West African frog, Xenopus tropicalis. The taxonomic position of the frog pathogen has not been fully elucidated, but this organism, tentatively designated Mycobacterium liflandii, is closely related to M. ulcerans and Mycobacterium marinum, and as further evidence is gathered, it will most likely be considered a subspecies of one of these species. In this paper we show that M. liflandii produces a novel plasmid-encoded mycolactone, mycolactone E. M. liflandii contains all of the genes in the mycolactone cluster with the exception of that encoding CYP140A2, a putative p450 monooxygenase. Although the core lactone structure is conserved in mycolactone E, the fatty acid side chain differs from that of mycolactone A/B in the number of hydroxyl groups and double bonds. The cytopathic phenotype of mycolactone E is identical to that of mycolactone A/B, although it is less potent. To further characterize the relationship between M. liflandii and M. ulcerans, strains were analyzed for the presence of the RD1 region genes, esxA (ESAT-6) and esxB (CFP-10). The M. ulcerans genome strain has a deletion in RD1 and lacks these genes. The results of these studies show that M. liflandii contains both esxA and esxB.
Barker,
Epidemiology of Mycobacterium ulcerans infection.
1973, Pubmed
Barker,
Epidemiology of Mycobacterium ulcerans infection.
1973,
Pubmed Brosch,
Use of a Mycobacterium tuberculosis H37Rv bacterial artificial chromosome library for genome mapping, sequencing, and comparative genomics.
1998,
Pubmed Cadapan,
Suspension cultivation of Mycobacterium ulcerans for the production of mycolactones.
2001,
Pubmed Chemlal,
Evaluation of PCR-restriction profile analysis and IS2404 restriction fragment length polymorphism and amplified fragment length polymorphism fingerprinting for identification and typing of Mycobacterium ulcerans and M. marinum.
2001,
Pubmed Connor,
Mycobacterium ulcerans infection (with comments on pathogenesis).
1965,
Pubmed Fidanze,
Complete structure of the mycolactones.
2001,
Pubmed Flint,
The RD1 virulence locus of Mycobacterium tuberculosis regulates DNA transfer in Mycobacterium smegmatis.
2004,
Pubmed Gao,
A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion.
2004,
Pubmed George,
A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells.
2000,
Pubmed George,
Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.
1999,
Pubmed George,
Partial purification and characterization of biological effects of a lipid toxin produced by Mycobacterium ulcerans.
1998,
Pubmed Hong,
Identification using LC-MSn of co-metabolites in the biosynthesis of the polyketide toxin mycolactone by a clinical isolate of Mycobacterium ulcerans.
2003,
Pubmed Hsu,
The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue.
2003,
Pubmed Jenkin,
Subtractive hybridization reveals a type I polyketide synthase locus specific to Mycobacterium ulcerans.
2003,
Pubmed Kazumi,
[Mycobacterium shinshuense isolated from cutaneous ulcer lesion of right lower extremity in a 37-year-old woman].
2004,
Pubmed Lewis,
Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation.
2003,
Pubmed MacCALLUM,
A new mycobacterial infection in man.
1948,
Pubmed Marmiesse,
Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex.
2004,
Pubmed Marsollier,
Aquatic insects as a vector for Mycobacterium ulcerans.
2002,
Pubmed Mve-Obiang,
Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence.
2003,
Pubmed Pym,
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.
2003,
Pubmed Snyder,
Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans.
2003,
Pubmed Stinear,
Identification and characterization of IS2404 and IS2606: two distinct repeated sequences for detection of Mycobacterium ulcerans by PCR.
1999,
Pubmed Stinear,
Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans.
2004,
Pubmed Stinear,
Comparative genetic analysis of Mycobacterium ulcerans and Mycobacterium marinum reveals evidence of recent divergence.
2000,
Pubmed Trott,
Characterization of a Mycobacterium ulcerans-like infection in a colony of African tropical clawed frogs (Xenopus tropicalis).
2004,
Pubmed
,
Xenbase van der Werf,
Mycolactones and Mycobacterium ulcerans disease.
2003,
Pubmed van der Werf,
Mycobacterium ulcerans infection.
1999,
Pubmed Volkman,
Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant.
2004,
Pubmed
